Messner, Donna A.
Rabins, P.
Downing, A.C.
Irizarry, M.
Foster, N.L.
Al Naber, J.
Dabbous, O.
Fillit, H.
Gabler, S.
Krakauer, R.
Lotz, D.
Payzant, E.
Schneider, L.
Tyrone, J.
Van Amerongen, D.
Wuest, D.
This article is maintained by: Elsevier
Article Title: Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
Journal Title: The Journal of Prevention of Alzheimer's Disease
CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2018.42
Content Type: article
Copyright: Copyright © 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS